{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:47:49Z","timestamp":1785876469171,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015098","name":"Seoul Metropolitan Government Seoul National University Boramae Medical Center","doi-asserted-by":"publisher","award":["03-2018-4"],"award-info":[{"award-number":["03-2018-4"]}],"id":[{"id":"10.13039\/501100015098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.diabres.2026.113388","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T22:07:39Z","timestamp":1782079659000},"page":"113388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The effect of rapid improvement of blood glucose level on diabetic neuropathy in Korean people with diabetes mellitus"],"prefix":"10.1016","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5318-0859","authenticated-orcid":false,"given":"Hun Jee","family":"Choe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Kyung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Ho","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Sung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Chan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Heon","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Lim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7430-3675","authenticated-orcid":false,"given":"Sin Gon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5460-2846","authenticated-orcid":false,"given":"Min Kyong","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.diabres.2026.113388_b0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113388_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41582-024-01041-y","article-title":"The global and regional burden of diabetic peripheral neuropathy","volume":"21","author":"Savelieff","year":"2025","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113388_b0015","first-page":"25","article-title":"Current status of diabetic peripheral neuropathy in Korea: report of a hospital-based study of type 2 diabetic patients in Korea by the diabetic neuropathy study group of the korean diabetes association","volume":"38","author":"Won","year":"2014","journal-title":"DiabetesMetab J"},{"key":"10.1016\/j.diabres.2026.113388_b0020","doi-asserted-by":"crossref","unstructured":"Diabetes C, Complications Trial Research G, Nathan DM, Genuth S, Lachin J, Cleary P, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977\u201386.","DOI":"10.1056\/NEJM199309303291401"},{"issue":"1","key":"10.1016\/j.diabres.2026.113388_b0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/dc13-2114","article-title":"Neuropathy and related findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Martin","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2026.113388_b0030","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113388_b0035","doi-asserted-by":"crossref","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837\u201353.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"issue":"10","key":"10.1016\/j.diabres.2026.113388_b0040","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/dc13-0012","article-title":"Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) cohort","volume":"36","author":"Pop-Busui","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113388_b0045","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee for D. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Supplement_1):S132\u2013S49.","DOI":"10.2337\/dc26-S006"},{"issue":"6","key":"10.1016\/j.diabres.2026.113388_b0050","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.4093\/dmj.2025.0978","article-title":"Bridging evidence and practice: a consensus statement from the korean diabetes association on diabetes screening, pharmacological treatment and severe diabetes","volume":"49","author":"Choi","year":"2025","journal-title":"Diabetes Metab J"},{"issue":"4","key":"10.1016\/j.diabres.2026.113388_b0055","first-page":"582","article-title":"2025 Clinical practice guidelines for diabetes management in Korea: recommendation of the Korean diabetes association","volume":"49","author":"Kang","year":"2025","journal-title":"DiabetesMetab J"},{"issue":"Pt 1","key":"10.1016\/j.diabres.2026.113388_b0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/awu307","article-title":"Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes","volume":"138","author":"Gibbons","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.diabres.2026.113388_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2020.102668","article-title":"Treatment induced neuropathy of diabetes","volume":"226","author":"Gibbons","year":"2020","journal-title":"Auton Neurosci"},{"issue":"3","key":"10.1016\/j.diabres.2026.113388_b0070","first-page":"454","article-title":"Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review","volume":"21","author":"Bain","year":"2019","journal-title":"DiabetesObes Metab"},{"issue":"1","key":"10.1016\/j.diabres.2026.113388_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabet.2017.10.014","article-title":"Standards for screeningand surveillance of ocular complications in people with diabetes SFDsg. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes","volume":"44","author":"Feldman-Billard","year":"2018","journal-title":"Diabetes Metab"},{"issue":"4","key":"10.1016\/j.diabres.2026.113388_b0080","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ana.21952","article-title":"Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy","volume":"67","author":"Gibbons","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.diabres.2026.113388_b0085","article-title":"Novel GLP-1-based medications for type 2 diabetes and obesity","author":"Son","year":"2025","journal-title":"Endocr Rev"},{"issue":"10208","key":"10.1016\/j.diabres.2026.113388_b0090","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(19)32131-2","article-title":"Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial","volume":"394","author":"Matthews","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.diabres.2026.113388_b0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022448","article-title":"Efficacy and tolerability of novel triple combination therapy in drug-naive patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial","volume":"8","author":"Kim","year":"2018","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.diabres.2026.113388_b0100","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.clinthera.2005.08.002","article-title":"Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy","volume":"27","author":"Bastyr 3rd","year":"2005","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.diabres.2026.113388_b0105","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","article-title":"Use of the Michigan neuropathy screening instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications","volume":"29","author":"Herman","year":"2012","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.diabres.2026.113388_b0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.clineuro.2005.08.003","article-title":"Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy","volume":"108","author":"Moghtaderi","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.diabres.2026.113388_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4441115","article-title":"The composite autonomic symptom score 31 questionnaire: a sensitive test to detect risk for autonomic neuropathy","volume":"2023","author":"Meling","year":"2023","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2026.113388_b0120","doi-asserted-by":"crossref","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycemia in type 2 diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753\u201386.","DOI":"10.2337\/dci22-0034"},{"key":"10.1016\/j.diabres.2026.113388_b0125","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee for D. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2026. Diabetes Care. 2026;49(Supplement_1):S183\u2013S215.","DOI":"10.2337\/dc26-S009"},{"issue":"4","key":"10.1016\/j.diabres.2026.113388_b0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.eprac.2026.01.006","article-title":"American association of clinical endocrinology consensus statement: algorithm for management of adults with type 2 diabetes - 2026 update","volume":"32","author":"Samson","year":"2026","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.diabres.2026.113388_b0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13098-022-00805-0","article-title":"Functional predictors of treatment induced diabetic neuropathy (TIND): a prospective pilot study using clinical and neurophysiological functional tests","volume":"14","author":"Hoffmann","year":"2022","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"10.1016\/j.diabres.2026.113388_b0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes ResClin Pract"},{"issue":"7","key":"10.1016\/j.diabres.2026.113388_b0145","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2337\/dc10-0125","article-title":"Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"33","author":"Pop-Busui","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2026.113388_b0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/dc20-1842","article-title":"Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes: the ACCORD trial","volume":"44","author":"Tang","year":"2021","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.diabres.2026.113388_b0155","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group AC","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.diabres.2026.113388_b0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726003086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726003086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:09:20Z","timestamp":1785874160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726003086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"alternative-id":["S0168822726003086"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113388","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of rapid improvement of blood glucose level on diabetic neuropathy in Korean people with diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113388"}}